Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
15.60
+0.16 (1.04%)
At close: Oct 3, 2025, 4:00 PM EDT
15.65
+0.05 (0.32%)
After-hours: Oct 3, 2025, 7:49 PM EDT
Syndax Pharmaceuticals Market Cap
Syndax Pharmaceuticals has a market cap or net worth of $1.34 billion as of October 3, 2025. Its market cap has decreased by -12.27% in one year.
Market Cap
1.34B
Enterprise Value
1.22B
1-Year Change
-12.27%
Ranking
Category
Stock Price
$15.60
Market Cap Chart
Since March 3, 2016, Syndax Pharmaceuticals's market cap has increased from $208.60M to $1.34B, an increase of 544.21%. That is a compound annual growth rate of 21.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 1.34B | 19.09% |
| Dec 31, 2024 | 1.13B | -25.02% |
| Dec 29, 2023 | 1.50B | -1.81% |
| Dec 30, 2022 | 1.53B | 41.76% |
| Dec 31, 2021 | 1.08B | 18.96% |
| Dec 31, 2020 | 908.90M | 281.41% |
| Dec 31, 2019 | 238.30M | 115.66% |
| Dec 31, 2018 | 110.50M | -48.29% |
| Dec 29, 2017 | 213.70M | 63.88% |
| Dec 30, 2016 | 130.40M | -37.49% |
| Mar 3, 2016 | 208.60M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |